A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis.
Robert BissonnetteCatherine MaariAthanasios TsianakasDeAnne ReidSara McCutchanScott BaumgartnerJames MackayNihar BhaktaPublished in: Dermatology and therapy (2021)
RIST4721-201 was registered in June 2019 at clinicaltrials.gov: NCT03988335.